Dr Reddy's Laboratories’ US-based arm-- Dr Reddy's Laboratories, Inc is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose. It is recalling 25,176 cartons of 30-count tablets and 22,968 cartons of 20-count tablets. According to USFDA, the company is recalling the affected lot due to ‘failed stability specifications’.
The New Jersey-based firm initiated the Class III recall on November 21, 2022. As per USFDA, a Class III recall is initiated in a ‘situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences’.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
